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P
ay-for-performance programs 
have been embraced by United 
States and United Kingdom 
policy makers and payors (those who 
pay for health-care services) as a means 
to improve the quality of health care. 
In fact, since the Institute of Medicine’s 
2001 report Crossing the Quality Chasm 
suggested realigning incentives to 
improve care [1], the UK’s National 
Health Service (NHS) introduced 
pay-for-performance (P4P) contracts 
for all family practitioners. In the US, 
more than half of commercial health 
maintenance organizations have 
started using such contracts, and recent 
legislation requires that the Centers for 
Medicare and Medicaid Services do the 
same for Medicare [2].
Despite growing enthusiasm for 
P4P programs in the policy and 
commercial sectors, the evidence to 
support their effectiveness is weak. 
Only a handful of studies have directly 
examined the impact of ﬁ  nancial 
incentives on improving health-care 
processes and outcomes, and the 
results of those studies are mixed (K. 
Coleman, K. L. Reiter, D. Fulwiler, 
unpublished data). Generally, studies 
show that modest improvements can 
be achieved on the measures that are 
explicitly incentivized, at least over 
the short term [3]. However, it is 
unclear whether the improvements 
are a result of the ﬁ  nancial incentives 
themselves rather than simply the 
increased focus on services resulting 
from measurement of performance and 
publication of data [4]. 
In addition to the lack of evidence 
supporting P4P programs, there are 
also concerns about the possible 
unintended consequences of 
implementing P4P. For example, 
in their evaluation of the NHS P4P 
program, Doran and colleagues found 
that the strongest predictor of high 
achievement (i.e., where a family 
practice successfully met a number 
of pre-speciﬁ  ed quality targets) was 
exception reporting—a practice 
where physicians can exempt certain 
patients from being included in their 
performance data due to medical or 
other reasons [5]. Exception reporting 
rates for physician practices ranged 
from 0% to 85.8%, with a median of 
6%. In addition to creating incentives 
for dishonest reporting of data, or 
gaming, we are starting to see evidence 
that P4P may undermine other 
important quality initiatives such as 
reducing health disparities. In the 
NHS program, family practices with a 
high proportion of patients who were 
living in single-parent or low-income 
households were less likely to meet the 
quality targets [5].
A New Study on P4P and Health 
Disparities
In a new study published in PLoS 
Medicine, Christopher Millett and 
colleagues more fully explore the link 
between health disparities and P4P 
[6]. The authors provide the ﬁ  rst look 
at the differential impact of the NHS 
P4P program on patients with diabetes 
from different ethnic groups, including 
black Caribbean, black African, Indian, 
Pakistani, Bangladeshi, white Irish, and 
white British. 
Using disease registers in 
Wandsworth, an ethnically diverse 
borough of London, the authors 
studied performance data on treatment 
targets for diabetes management, 
examining the management and 
control of glycated hemoglobin, 
cholesterol, and blood pressure 
before and after the implementation 
of the NHS P4P program. Though 
improvements in process and outcomes 
were seen across most ethnic groups, 
the black Caribbean group had 
substantially lower improvements 
in glycated hemoglobin levels and 
blood pressure control than the white 
British group, reinforcing pre-existing 
disparities.
The authors also found some 
evidence that different ethnic groups 
received different treatment for their 
hyperglycemia: black and South 
Asian patients more often received 
oral hypoglycemic agents and white 
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Linked Research Article 
This Perspective discusses the 
following new study published in PLoS 
Medicine:
Millett C, Gray J, Saxena S, Netuveli G, 
Khunti K, et al. (2007) Ethnic disparities 
in diabetes management and pay-for-
performance in the UK: The Wandsworth 
Prospective Diabetes Study. PLoS 
Med 4(6): e191. doi:10.1371/journal.
pmed.0040191
Based on a population-based 
longitudinal survey, Christopher Millett 
and colleagues concluded that pay-for-
performance incentives for UK general 
practitioners had not addressed disparities 
in the management and control of 
diabetes between ethnic groups.PLoS Medicine  |  www.plosmedicine.org 0985
patients more often received insulin 
prescriptions. 
Limitations in the study design—
including the inability to adjust for 
clinically relevant confounders such 
as disease severity, duration, and 
complications—make it difﬁ  cult 
to interpret these ﬁ  ndings. The 
differential prescribing patterns 
and outcomes could be attributable 
to anything from medical necessity 
or patient preference to systematic 
differences in self-management 
behaviors or provider bias. Despite 
these caveats, the study does prompt 
continued exploration of the 
intersection of popular P4P programs 
and their impact on health disparities. 
The study also encourages us to think 
more deeply about how incentive 
programs may unintentionally amplify 
existing differences in health between 
different ethnic groups. 
Policy Implications
As major P4P projects such as Medicaid 
programs and others begin [7], we have 
the opportunity to integrate important 
lessons learned. Early evidence does 
not support the position of some 
commentators who believed P4P could 
be a “silver bullet” to improve health-care 
quality and reduce costs [8]. Instead, 
as Millett and colleagues show, P4P 
alone may not be able to drive equitable 
improvement in health-care quality. 
How can we ensure that P4P 
programs help us to achieve the 
quality goals that we have set for 
ourselves, including a reduction in 
health disparities? First, we must 
ensure that performance-based pay 
is not the sole mechanism driving 
quality improvement. Instead, if we 
contextualize P4P as part of a larger 
quality improvement effort, then we 
can leverage demonstrated quality 
improvement paradigms, such as the 
Chronic Care Model [9], and use P4P 
to reinforce program goals. 
Next, the literature shows us that 
we must be clear about what processes 
and outcomes are expected to change 
with P4P, and we must align ﬁ  nancial 
incentives and improvement efforts 
with those expectations [3]. If we want 
to reduce health disparities, we have to 
focus efforts on progress toward that 
goal. Millett and colleagues show us 
that we cannot assume that a quality 
improvement effort will beneﬁ  t all 
patients equally. 
Finally, one way to reduce such 
disparities is to create opportunities 
for local goal setting. Though large 
scale policy-making bodies such as 
Medicare and the NHS set broad 
improvement agendas, the unique 
characteristics of regions such as 
Wandsworth highlight the importance 
of ﬂ  exible performance measures. 
Health care is, after all, local. We need 
to recognize the diversity of contexts 
within which health services operate 
to achieve the improvements in quality 
and the reduction in disparities to 
which we aspire.  
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